Skip to content
eventVerified

U.S. cisplatin and carboplatin shortages followed Intas quality shutdown

Dated 1 June 2023: U.S. cisplatin and carboplatin shortages followed Intas quality shutdown. In the causal graph this event strengthens Access to Essential Medicines, a driver that weakens Proportion of the population with positive out-of-pocket household expenditure on health exceeding 40% of household discretionary budget, by location, quintile, type of household and characteristics of the head of household (%) — an improving welfare path.

Who was responsible

Contribution type and responsibility level for each recorded actor — not sole-author shorthand.

No public contributors are listed for this fact.

What changed

Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.

Causal path

How this event connects to drivers and indicators in the graph.

  1. FactU.S. cisplatin and carboplatin shortages followed Intas quality shutdown
  2. strengthensDriverAccess to Essential Medicines
  3. weakensIndicatorProportion of the population with positive out-of-pocket household expenditure on health exceeding 40% of household discretionary budget, by location, quintile, type of household and characteristics of the head of household (%)

Cite this page

Factrail. (2026). U.S. cisplatin and carboplatin shortages followed Intas quality shutdown. Factrail. https://factrail.ai/facts/us-cisplatin-carboplatin-cancer-shortage-2023

https://factrail.ai/facts/us-cisplatin-carboplatin-cancer-shortage-2023

Accessed 15 October 2026.

By the Factrail desk · Method: how we source and score · Last reviewed

Dispute this factNamed here, or represent someone who is? Request a right of reply.